PRN Communications Inc.

Selected Works

Articles

Kaufman MB./​ Drug Updates and Bisphosphonate Safety. The Rheumatologist 2009;3(5):1,19,20.

Kaufman MB. Pharmacogenomics: Up Close and Personal – Medication reaction research could streamline drug trials, improve outcomes. The Hospitalist 2009;13(5):14.

Kaufman MB. Health help 4 u: Mobile telephone technologies come of age. Formulary 2009;44:154-155.

Kaufman MB. Drug Watch: Cystic Fibrosis. Formulary 2009;44(5):156.

Kaufman MB. Drug Watch: Complicated Infections. Formulary 2009;44(4):124.

Kaufman MB. Rx Report. Dialysis & Transplantation 2009;38(4):146.

Kaufman MB. To Crush or Not to Crush! The Hospitalist 2009;13(4):18.

Kaufman MB. Rx Report. Dialysis & Transplantation 2009;38(3):108.

Kaufman MB. Drug Updates. The Rheumatologist 2009;3(3):1,18,19.

Kaufman MB. C. Difficile Infection: Are We Doing Enough? Hospitalists can follow simple steps to avoid, manage this costly disease. The Hospitalist 2009;13(3):12,26.

Kaufman MB. QTc Interval Prolongation: Know your patient’s history, drug combinations before starting a new treatment. The Hospitalist 2009;13(2):7.

Kaufman MB. Rx Technology Report: Preventable medication errors: Look-alike/​sound-alike mix-ups. Formulary 2009;44(2):59.

Kaufman MB. Drug Updates and Statin-Associated Myopathy. The Rheumatologist 2009;3(1):1,17,18.

Campbell M, Kaufman MB, Bendix J. Oral Oncology Drugs Navigating dispensing, billing, and reimbursement challenges is a daunting but not insurmountable task. Drug Topics , February 1, 2009.

Kaufman MB. Telepharmacy reaches out to the underserved Formulary Journal 2009 http:/​/​formularyjournal.modernmedicine.com/​formulary/​ArticleStandard/​Article/​detail/​575698

Kaufman MB. Inhaled Insulin: Troubled Drug Rises from the Ashes. The Hospitalist 2009;13(1):10.

Kaufman MB. End of ’08 Drug Update. The Hospitalist 2008;12(12):18.

Kaufman MB. Rx Report. Dialysis & Transplantation 2008;37(12):506,513.

Kaufman MB. Drugs that Cause Movement Disorders. The Hospitalist 2008;12(10):17.

Kaufman MB. Rx Report. Dialysis & Transplantation 2008;37(10):411,412.

Kaufman MB. Serotonin Syndrome. The Hospitalist 2008;12(9):13.

Kaufman MB. Drug Watch: Agents in late stage development for Types 1 and 2 Diabetes Mellitus. Formulary 2008;43(9):344. Available at:
http:/​/​formularyjournal.modernmedicine.com/​formulary/​data/​articlestandard/​/​formulary/​352008/​546160/​article.pdf

Navigating an Emerging Crossroad: Patient, Provider and Payer Considerations in Biologic Therapies for Immune-mediated Diseases (Medical Writer) September 2008. A four hour CME/​CE monograph for physicians, pharmacists, nurse practitioners, physician’s assistants, nurses and case managers. Available at: http:/​/​primeinc.org/​course/​149.html

Kaufman MB. Drug Watch: Adult and juvenile rheumatoid arthritis. Formulary 2008;43(7):260. Available at: http:/​/​formularyjournal.modernmedicine.com/​formulary/​data/​articlestandard/​/​formulary/​272008/​526907/​article.pdf

Kaufman MB. Rx Report. Dialysis & Transplantation 2008;37(6):214.

Kaufman MB. Be Aware of Agents associated with Drug-Induced Thrombocytopenia. The Hospitalist 2008;12(6):22.

Patient Encounters: Real Faces of Biologic Treatment in Related Disease Pathologies. Contributing Author for Live Symposia (slides and speaker notes) at the 18th Annual Case Management Society of America Annual Conference and Expo, Orlando, FL, June 18, 2008.

Kaufman MB. Rx Technology Report: Electronic medication management system available to improve medication adherence. Formulary 2008;43(6):223. Available at: http:/​/​formularyjournal.modernmedicine.com/​

Kaufman MB. Rx Technology Report: High-tech solutions to reduce the incidence of hospital-acquired infections and antibiotic resistance. Formulary Journal online May 2008. Available at: http:/​/​formularyjournal.modernmedicine.com/​

Kaufman MB. Protect the Platelets – Be Aware of agents associated with drug-induced thrombocytopenia. The Hospitalist 2008;12(5):22.

Capitalizing on Collaborative Strategies to Improve Care for Patients with Cystic Fibrosis. Contributing Author for Live Regional Symposia (slides and speaker notes), Spring 2008.

Navigating an Emerging Crossroad: Patient, Provider, and Payer Considerations in Biologic Therapies for Immune-mediated Diseases. Contributing Author for Live Symposia (slides and speaker notes). The 2008 Academy of Managed Care Pharmacy Annual Meeting, San Francisco, CA, April 18, 2008.

To Treat or Not to Treat? Debating the Utility of Antithrombotic Therapy in the Long-term Care Population. Contributing Author for Live Program (slides and speaker notes). American Medical Directors Association Meeting, March 6-9, 2008, San Diego, CA.

Kaufman MB. Vital VTE Intervention – Many hospitalized patients are at risk and need thromboprophylaxis. The Hospitalist 2008;12(4):15.

ASA Therapy and Beyond: Assessing the Current Role of Antiplatelet Therapy, Contributing Author for Live Program at the Society for Hospital Medicine Annual Meeting, April 4, 2008, San Diego, CA; and Contributing Author for online video presentation (slides and speaker notes) for continuing professional education available at: http:/​/​www.primeinc.org

Kaufman MB. Combat Adverse Events – Expanded FDA regulations bring new drug warnings. The Hospitalist 2008;12(3):13.

Kaufman MB. Rx Report. Dialysis & Transplantation 2008;37(3):106-107.

Kaufman MB. Liver Risks Abound – Acetaminophen leads other agents as cause of hepatotoxicity. The Hospitalist 2008;12(2):14.

Kaufman MB. Rx Report. Dialysis & Transplantation 2008;37(1):32-33.

Kaufman MB. Rx Technology Report: Bar coding helps improve patient safety. January 2008;43(1):30.

Kaufman MB. Manage Cancer Drugs – Renal function caveats. The Hospitalist 2008;12(1):14.

Kaufman MB. Avoid Pancreatitis Risk – More than 100 Medication have been implicated in this condition. The Hospitalist 2007;11(12):13-14.

Kaufman MB. Manage Cancer Drugs – How to handle the side effects of cell regulating medications. The Hospitalist 2007;11(11):13,16. Available at:
http:/​/​www.the-hospitalist.org/​issues.asp

Kaufman MB. Rx Report. Dialysis & Transplantation 2007;36(11):616-617. Available at http:/​/​www3.interscience.wiley.co

Kaufman MB. Stress Ulcer Agents – Sucralfate, H2 receptor antagonists are valid classes. The Hospitalist 2007;11(10):13. Available at:
http:/​/​www.the-hospitalist.org/​issues.asp

Kaufman MB. Rx Report.Dialysis and Transplantation 2007;36(10):554-555. Available at http:/​/​www3.interscience.wiley.co

Kaufman MB. Steroid Stress Dosing – How to negotiate the use of glucocorticoids. The Hospitalist 2007;11(9):12-13. Available at:
http:/​/​www.wiley.com/​WileyCDA/​Section/​id-292144.html

Kaufman MB. Rx Report.Dialysis and Transplantation 2007;36(8):460-461. Available at http:/​/​www3.interscience.wiley.co

Kaufman MB. Rx Technology Report: How High-Tech Advances and Applications are Impacting Health-System and Managed-Care Pharmacy. Formulary Journal
Available at: http:/​/​www.formularyjournal.com

Web-based tools to improve case management.
Formulary 2007;42(6):408.

Automated IV and syringe preparation increases
safety, reduces errors.
Formulary 2007;42(5):327.

E-prescribing offers a neat and safe alternative to
pad and pen.
Formulary 2007;42(4):250.

RFID goes to work to help prevent errors,
tampering.
Formulary 2007;42(3):197.

New diagnostic tool aids in pathogen
identification; kiosks in doctors' offices provide
generic drug samples.
Formulary 2007;42(2):126.

Personal health records go portable; hospitals tap
into translation services by video.

Formulary 2007;42(1):55.

Kaufman MB. Rx Report: New Safety Warnings Released.
Dialysis and Transplantation 2007;36(6):321. Available at http:/​/​www3.interscience.wiley.com

Hemoglobin Levels in CKD: What’s the Correct Level? Dialysis & Transplantation 2007;46(4): 236-237.

The Year in Review. Dialysis & Transplantation 2006;35(12):778-779.

Rx Report – The New Anemia Drugs. Dialysis & Transplantation 2006;35(9):588,590.

Plotting a Course to Manage Rheumatoid Arthritis. October 2007, Contributing Author for online video presentation (slides and speaker noted) for continuing professional education. Visit http:/​/​www.primeinc.org to access programs.

Plotting a Course to Manage Inflammatory Bowel Disease. October 2007, Contributing Author for online video presentation (slides and speaker noted) for continuing professional education. Visit http:/​/​www.primeinc.org to access programs.

Case Studies Optimizing Management of Depression and Anxiety. June 2007, contributing author for online video presentation (slides and speaker notes) for continuing professional education. Visit http:/​/​www.primeinc.org to access programs.

Interactive Discussion in the Current State of Diabetes Care January 2007: Contributing Author for online dynamic video presentation (slides and speaker notes) for continuing education.

Modernization Versus Limitation: Cross-Firing the Impact of the AHRQ Effective Health Care Program on Access to Biologic Therapies
Chao S, Fleming W, Solomon D, Urbano F. Journal of Managed Care Pharmacy Supplement 2007;13:S1-28. Contributing Author/​Medical Writer Available at: http:/​/​www.amcp.org/​data/​jmcp/​JanSuppl07.pdf

From Asthma Severity to Asthma Control – Identification of New Guideline Application.
Jones C, Endicott L, Kaufman MB. Supplement to Journal of Managed Care Pharmacy 2006;12:S1-S17. http:/​/​amcp.org/​data/​jmcp/​Dec_suppl.pdf

The Hospital Pharmacy – Pain Killers: Agents to manage neuropathic pain in hospitalized patients. Kaufman MB. The Hospitalist 2006;10(9):11.

“Case-Based Approaches to Managing Future Formularies for Immune-Mediate Disease” June 2006: Contributing Author for online dynamic presentation for continuing education (slides and audio) Available at: http:/​/​www.primeinc.org/​

“Optimizing Treatment Outcomes in Patients with Chemotherapy-Related Anemia” July 2006: Contributing Author for online dynamic video presentation for continuing education (slides and speaker notes). Information available through: http:/​/​www.primeinc.org/​

“Breathing Easier: Using Evidence to Improve Outcomes for Patients with COPD” September 2006: Contributing Author for live one-hour presentations for continuing education (slides and speaker notes).

The Hospital Pharmacy -- Two New Insulin Products -- the scoop hospitalists need to know about Exubera and Levemir. Kaufman MB. The Hospitalist 2006;10:18-19.

Editorials available on at http:/​/​www.primeinc.org under Pharmacist "Case Studies"

March 2006: "To Sleep or Not to Sleep"

February 2006: "Generic Biotechnology Drug
Products"


January 2006: Disparities in Healthcare

December 2005: Revisiting Alcohol ‘Tis the Season
to be Jolly – But Don’t Overdo It


November 2005: : The Avian Influenza (H5N1) Primer
for Pharmacists


October 2005: Where Are We Going with HIV/​AIDS?

September 2005: What’s New Since My Last Editorial
on Direct-to-Consumer Advertising (DTCA, June
2005)?


July 2005: Diabetes Treatments in 2005

June 2005: Impact of Direct-to-Consumer
Advertising


A Growth Hormone Conversion Program and Patient Outcomes at a not-for-profit HMO. Kaufman MB, Brodin KA, Sarafian A. Formulary 2006;41:82-90.

Effect of Prescriber Education on the Use of Medications Contraindicated in Older Patients in a Managed Medicare Population. Kaufman MB, Brodin KA, Sarafian A. Journal of Managed Care Pharmacy 2005;11:211-219.

A Treatment Conversion for Hepatitis C Virus (HCV). Kaufman MB, Magagna M, Brodin KA, Sarafian A.Supplement to Managed Healthcare Executive; April 2005;6-10.

Use of Proton-Pump Inhibitors at a Nonprofit, Mixed-Model Health Maintenance Organization. Kaufman MB, Alimonos K, Sarafian A. American Journal of Health-Systems Pharmacy 2004;61:2244-2246.

Can Mycophenolate Mofetil be used to Treat Lupus Nephritis, a Renal Manifestation of Systemic Lupus Erythematosus? Kaufman MB. US Pharmacist; October 2000:HS-22, HS-28, HS-30 & HS-31.

"Drug Watch" -- A Heads-Up on Pharmaceuticals in Late Stage Development. Formulary (January 1999 – present): Contributing Authors: Stultz T, Kaufman MB. Last page of journal each month at http:/​/​www.formularyjournal.com

A Review of Protease Inhibitor-induced Hyperglycemia. Kaufman MB, Simionatto C. Pharmacotherapy 1999;19:114-117.

Myoclonus from calcium channel blockers. Kaufman MB. US Pharm - Health Systems Edition 1996;August:82-6.

Feature Article: Acquired Immunodeficiency (AIDS) Treatment Review. Contributing Author/​wrote feature Pharmacy and Therapeutics Newsletter of the Health Insurance Plan of Greater New York, Volume 7, Number 3 [Summer 1996 issue].


Bone and tissue changes following prostaglandin therapy in neonates. Kaufman MB, El-Chaar GM. Annals of Pharmacotherapy 1996;30:269-274,277.

Role of a pharmacist at resident physician's morning report in adverse drug reaction reporting. Kaufman MB. American Journal of Health-Systems Pharmacy 1995;52:2031.

Adverse effects associated with dexamethasone, lorazepam and granisetron [letter].Kaufman MB. Annals of Pharmacotherapy 1994;28:1306-1307.

Dystonic reaction associated with sumatriptan [letter]. Garcia G, Kaufman MB, Colucci RD. Annals of Pharmacotherapy 1994;28:1199.

Physician's liability for adverse drug reactions. Kaufman MB, Stoukides CA, Campbell NA. Southern Medical Journal 1994;87:780-784.

Galactopharmacopedia: Antihistamines in breast-feeding. Ghaeli P, Kaufman MB. J Hum Lact 1993;4:261-2.

Stability of undiluted trimethoprim-sulfamethoxazole for injection in plastic syringes. Kaufman MB, Scavone JM, Foley JJ. American Journal of Hospital Pharmacy 1992;49:2782-2783.

Corticosteroids in AIDS patients with Pneumocystis carinii pneumonia. Kaufman MB, DeMuria D.Annals of Pharmacotherapy 1992;26:932-933.

Acute renal failure associated with over-the-counter ibuprofen. Spierto RJ, Kaufman MB, Stoukides CA. Annals of Pharmacotherapy 1992;26:714.

Portuguese man-o-war envenomation. Kaufman MB. Pediatric Emergency Care 1992;8:27-28.

Angiotensin-converting enzyme inhibitors: class effects. Stoukides CA, Kaufman MB. The ADR Exchange 1991;4(4).

Ipecac intoxication. Kaufman MB. Clinical Toxicology Review 1990;13.